Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105YAMAMOTO, Nobuyuki; NAKAGAWA, Kazuhiko; SAWA, Toshiyuki et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3739-3745, issn 0732-183X, 7 p.Article

Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung CancerKOHMO, Satoshi; KIJIMA, Takashi; YOSHIDA, Mitsuhiro et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 20, pp 8025-8035, issn 0008-5472, 11 p.Article

Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung CancerTAKAHASHI, Toshiaki; YAMAMOTO, Nobuyuki; SEGAWA, Yoshihiko et al.Anticancer research. 2010, Vol 30, Num 2, pp 557-563, issn 0250-7005, 7 p.Article

Short-Term Gefitinib Treatment Brought About a Long-Term Regression of Bronchioloalveolar Carcinoma Without EGFR Gene Alterations : A Case ReportKIJIMA, Takashi; SUZUKI, Mayumi; TACHIBANA, Isao et al.Oncology research. 2007, Vol 16, Num 10, pp 489-495, issn 0965-0407, 7 p.Article

Simultaneous bilateral spontaneous pneumothorax observed during the administration of gefitinib for lung adenocarcinoma with multiple lung metastasesMORI, Masahide; NAKAGAWA, Masaru; OKADA, Tatsuya et al.Internal medicine (Tokyo. 1992). 2005, Vol 44, Num 8, pp 862-864, issn 0918-2918, 3 p.Article

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese Taxotere Lung Cancer Study GroupKUBOTA, Kaoru; WATANABE, Koshiro; YONEDA, Shuichi et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 254-261, issn 0732-183X, 8 p.Article

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapyAZUMA, Junichi; OHNO, Masako; KAWASE, Ichiro et al.European journal of clinical pharmacology. 2013, Vol 69, Num 5, pp 1091-1101, issn 0031-6970, 11 p.Article

Interstitial Lung Disease in Japanese Patients with Lung Cancer : A Cohort and Nested Case-Control StudyKUDOH, Shoji; KATO, Harubumi; HAIYI JIANG et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1348-1357, issn 1073-449X, 10 p.Article

Postoperative serum carcinoembryonic antigen levels in patients with pathologic Stage IA nonsmall cell lung carcinoma: Subnormal levels as an indicator of favorable prognosisSAWABATA, Noriyoshi; MAEDA, Hajime; YOKOTA, Soichiro et al.Cancer. 2004, Vol 101, Num 4, pp 803-809, issn 0008-543X, 7 p.Article

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancerNIHO, Seiji; KUNITOH, Hideo; MATSUI, Kaoru et al.Lung cancer. 2012, Vol 76, Num 3, pp 362-367, issn 0169-5002, 6 p.Article

Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancerTAKEDA, Shin-Ichi; MAEDA, Hajime; OKADA, Tatsuya et al.European journal of cardio-thoracic surgery. 2006, Vol 30, Num 1, pp 184-189, issn 1010-7940, 6 p.Article

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell Lung cancer: Results of the japan clinical Oncology Group Study 9104TAKADA, Minoru; FUKUOKA, Masahiro; FUKUDA, Haruhiko et al.Journal of clinical oncology. 2002, Vol 20, Num 14, pp 3054-3060, issn 0732-183XArticle